Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological effects of berberine on mood disorders
Jie Fan, Kun Zhang, Yang Jin, et al.
Journal of Cellular and Molecular Medicine (2018) Vol. 23, Iss. 1, pp. 21-28
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Biological Activity of Berberine—A Summary Update
Anna Och, Rafał Podgórski, Renata Nowak
Toxins (2020) Vol. 12, Iss. 11, pp. 713-713
Open Access | Times Cited: 164
Antiviral activity of berberine
Alicja Warowicka, Robert Nawrot, Anna Goździcka‐Józefiak
Archives of Virology (2020) Vol. 165, Iss. 9, pp. 1935-1945
Open Access | Times Cited: 144
Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption
Zongshi Qin, Dongdong Shi, Wenqi Li, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 70
Palmatine: A review of pharmacological properties and pharmacokinetics
Dominik Tarabasz, Wirginia Kukuła‐Koch
Phytotherapy Research (2019) Vol. 34, Iss. 1, pp. 33-50
Closed Access | Times Cited: 99
Coptisine fromCoptis chinensisexerts diverse beneficial properties: A concise review
Jiasi Wu, Yu Luo, Donghang Deng, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 12, pp. 7946-7960
Open Access | Times Cited: 87
Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease
Anna Och, Marek Och, Renata Nowak, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1351-1351
Open Access | Times Cited: 51
Berberine: A Promising Treatment for Neurodegenerative Diseases
Ziqian Cheng, Chenglan Kang, Songtian Che, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice
Xinyu Wang, Jiamin Zhang, Sisi Wang, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175782-175782
Open Access | Times Cited: 24
Coptisine improves LPS-induced anxiety-like behaviors by regulating the Warburg effect in microglia via PKM2
Yiyu Qi, Xin Zhao, Weizhen Wu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117837-117837
Open Access | Times Cited: 1
Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent
Quintero Vargas Jael Teresa de Jesús, J.C. Galvez-Ruiz, Adriana Alejandra Márquez Ibarra, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 193-193
Open Access | Times Cited: 1
Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation
Ziyi Zhao, Jinhao Zeng, Qiang Guo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Berberine ameliorates depression‐like behavior in CUMS mice by activating TPH1 and inhibiting IDO1‐associated with tryptophan metabolism
Pingyuan Ge, Shu‐Yue Qu, Sai‐jia Ni, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 1, pp. 342-357
Closed Access | Times Cited: 36
Phytotherapeutic applications of alkaloids in treating breast cancer
Shailima Rampogu, Thananjeyan Balasubramaniyam, Joon‐Hwa Lee
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113760-113760
Open Access | Times Cited: 30
Optic Nerve Neuroprotection in Glaucoma: A Narrative Review
Angela DʼAngelo, Livio Vitiello, Filippo Lixi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2214-2214
Open Access | Times Cited: 6
Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell Lines
Anna Och, Daniel Zalewski, Łukasz Komsta, et al.
Toxins (2019) Vol. 11, Iss. 9, pp. 485-485
Open Access | Times Cited: 52
Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol
Milad Ashrafizadeh, Sara Javanmardi, Masoumeh Moradi-Ozarlou, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 49
Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways
Xiaotong Wang, Qianyi Gong, Changfeng Song, et al.
Toxicology and Applied Pharmacology (2021) Vol. 418, pp. 115484-115484
Closed Access | Times Cited: 39
Berberine and Ginsenoside Rb1 Ameliorate Depression-Like Behavior in Diabetic Rats
Jinghua Zhang, Huizeng Yang, Hao Su, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 05, pp. 1195-1213
Closed Access | Times Cited: 36
A bird's eye view on a therapeutically ‘wonder molecule’: Berberine
Parth Patel
Phytomedicine Plus (2021) Vol. 1, Iss. 3, pp. 100070-100070
Open Access | Times Cited: 33
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
Zhiyu Jin, Yu Han, Danshen Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2070-2070
Open Access | Times Cited: 23
Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases
Hanlong Wang, Shasha Liu, Yang Sun, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102472-102472
Closed Access | Times Cited: 5
Resveratrol, a popular dietary supplement for human and animal health: Quantitative research literature analysis - a review
Andy Wai Kan Yeung, Bharat B. Aggarwal, İlkay Erdoğan Orhan, et al.
Animal Science Papers and Reports (2019) Vol. 37, Iss. 2, pp. 103-118
Closed Access | Times Cited: 42
Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy
Shalini Mani, Geeta Swargiary, Stephen J. Ralph
Mitochondrion (2021) Vol. 62, pp. 50-73
Closed Access | Times Cited: 31
Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats
Azidah Abdul Kadir, Jasdeep Singh, Vikrant Rahi, et al.
Neurochemical Research (2022) Vol. 47, Iss. 11, pp. 3285-3297
Closed Access | Times Cited: 22
Investigation of berberine and its derivatives in Sars Cov-2 main protease structure by molecular docking, PROTOX-II and ADMET methods: in machine learning and in silico study
Erkan Öner, Khattab Al-Khafaji, Mezher H. Mezher, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9366-9381
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top